A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
The field of cancer immunology has seen significant advancements in recent years, particularly with the emergence of immunotherapy as a key pillar in the ...
Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, independent of tumor influence.
UC San Francisco Chancellor emeritus J. Michael Bishop, MD, a pioneering microbiologist who shared the 1989 Nobel Prize in ...
T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.
New AI tool uses gene activity patterns to predict cancer spread, helping doctors identify high-risk patients and personalize ...
The Sociable on MSN
From one donor, thousands of doses: Meet the startup making cell therapy accessible
Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing autoimmune disease and ...
OverT Bio forms Clinical Advisory Board to advance OVT-101, a scalable CAR-T therapy targeting CLDN6 for ovarian and other solid tumors.
Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...
Recent data suggests people taking GLP-1 drugs may develop colorectal cancer less often than those taking aspirin, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results